Skip to main content
. Author manuscript; available in PMC: 2016 May 27.
Published in final edited form as: Nurs Manage. 2016 Apr;47(4):23–26. doi: 10.1097/01.NUMA.0000481844.50047.ee

Table 1.

Genomics and the healthcare continuum4

Healthcare continuum Genomic application example Clinical application example
Preconception/prenatal Germline genetic testing for recessive conditions Preconception testing for carrier status in prospective parents for genetic variants associated with recessive conditions, such as sickle cell disease, cystic fibrosis, and Tay Sachs disease18
Cell-free fetal DNA from maternal plasma Less invasive strategy compared with amniocentesis for assessing fetal genomic variations that have health implications such as fetal aneuploidy19
Newborn screening State-mandated newborn screening; not all recommended screening tests are genetic tests, but they screen for indications of the need for further genetic evaluation Approximately 4 million newborns screened annually using dried blood spot cards for conditions such as immunodeficiency disorder and congenital heart disease20
Disease susceptibility Germline genetic testing Inherited cancer syndromes, such as hereditary breast ovarian syndrome, associated with mutations in BRCA1 and BRCA221
Familial hypercholesterolemia associated with mutations in LDLR, APOB, and PCSK922
Screening and diagnosis Stool DNA testing FDA-approved test that can be used for screening purposes instead of colonoscopy23
Prognosis and therapeutic decisions Targeted therapies Therapy based on tumor genomic variation, such as epidermal growth factor receptor somatic mutation in non–small cell lung cancer and tyrosine kinase inhibitors24
Tumor profiling Basket trials, such as the Molecular Analysis for Therapy Choice, or NCI-MATCH, designed to identify somatic mutations/amplifications/translocations in patient tumor samples and assign patients to agents/regimens based on tumor genomics and not histology25
Pharmacogenomics Individuals who carry HLA-B*57:01 have an increased risk of hypersensitivity to the antiretroviral drug abacavir26
Monitoring disease burden and recurrence Pharmacogenomics Symptom management such as pain control; CYP2D6 to determine whether an individual can convert codeine into the active metabolite morphine26